Philipp Sommer

Sep 12, 2023 | mdedge.com | John Mandrola |Christian Sohns |Philipp Sommer

Publish date: September 12, 2023 Recorded Aug. 28, 2023. This transcript has been edited for clarity. John M. Mandrola, MD: I’m here at the European Society of Cardiology meeting, and I’m very excited to have two colleagues whom I met at the Western Atrial Fibrillation Symposium (Western AFib) and who presented the CASTLE-HTx study. This is Christian Sohns and Philipp Sommer, and the CASTLE-HTx study is very exciting.

Sep 8, 2023 | medscape.com | John Mandrola |Christian Sohns |Philipp Sommer

Recorded August 28,2023. This transcript has been edited for clarity. John M. Mandrola, MD: Hi, everyone. This is John Mandrola from theheart.org | Medscape Cardiology. I'm here at the European Society of Cardiology meeting, and I'm very excited to have two colleagues whom I met at the Western Atrial Fibrillation Symposium (Western AFib) and who presented the CASTLE-HTx study, This is Christian Sohns and Philipp Sommer, and the CASTLE-HTx study is very exciting.

Aug 28, 2023 | cfrjournal.com | Harriette Van Spall |Mikhail Kosiborod |Christian Sohns |Philipp Sommer

ESC 23 - Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial. Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese.

Aug 28, 2023 | cfrjournal.com | Jozine ter Maaten |Harriette Van Spall |Christian Sohns |Philipp Sommer

ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927). PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes.

Aug 18, 2023 | cfrjournal.com | Harriette Van Spall |Christian Sohns |Philipp Sommer |Jozine ter Maaten

ESC 23 - Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Javed Butler (University of Mississippi Medical Center, US) to discuss the findings from the RECORD MI Registry. Recurrent myocardial infarction (MI) and new onset heart failure (HF) are major adverse complications in patients post-MI. Advances have been made for systems of care, coronary revascularization and drug therapy for the secondary prevention of myocardial infarction.